Faisal Khurshid
Leerink Partners | Healthcare
Faisal Khurshid is an analyst from Leerink Partners specializing in the Healthcare sector. Ranked #153 out of 4371 analysts, they have issued 14 stock ratings with a success rate of 92.23% and an average return of 64.16%.
With 14 ratings to date, Faisal Khurshid is beginning to establish credibility in the Healthcare sector. They have achieved a success rate of 92.23% and an average return of 64.16%, highlighting promising potential as their track record develops further.
Recent Ratings Analysis
GLPG
BuyOct 21, 2025
Target
$40.00
Current
$32.03
Performance
1.91%
Faisal Khurshid rated GLPG as Outperform on Oct 21, 2025, setting a price target of 40. Shares have remained stable near 32.03, leaving the 40 target still in play.
CTNM
BuySep 25, 2025
Target
$20.00
Current
$11.12
Performance
2.39%
On Sep 25, 2025, CTNM was given a Outperform rating by Faisal Khurshid, with a target price of 20. The stock traded sideways with a 2.39% move, keeping the bullish thesis unresolved.
PTGX
BuySep 12, 2025
Target
$73.00
Current
$73.98
Performance
25.70%
PTGX received a Outperform rating from Faisal Khurshid on Sep 12, 2025, aiming for 73. Momentum has favored the Buy call, with shares climbing from 73.985 to 73.985, rewarding those who trusted the recommendation.
STTK
BuyAug 14, 2025
Target
$2.00
Current
$1.85
Performance
115.02%
On Aug 14, 2025, Faisal Khurshid published a Outperform outlook on STTK, with a target of 2. Shares gained 115.02%, underscoring the accuracy of the bullish outlook toward 2.
RYTM
BuyJul 10, 2025
Target
$102.00
Current
$109.12
Performance
22.55%
Faisal Khurshid on Jul 10, 2025 assigned RYTM a Outperform rating, with a price target of 102. The Buy call aligned well with market performance, producing a gain of 22.55%.
ABCL
BuyJul 07, 2025
Target
$5.00
Current
$5.71
Performance
41.69%
On Jul 07, 2025, Faisal Khurshid reaffirmed ABCL with a Outperform rating, targeting 5. The recommendation was supported by strong follow-through as the stock rose from 5.71 to 5.71.
SYRE
BuyApr 08, 2025
Target
$45.00
Current
$22.37
Performance
89.58%
SYRE was rated Outperform by Faisal Khurshid on Apr 08, 2025, with a price objective of 45. A bullish response from the market helped close the gap of 22.63 to the target.
NRIX
HoldMar 17, 2025
Target
$16.00
Current
$10.40
Performance
-25.34%
On Mar 17, 2025, Faisal Khurshid initiated coverage on NRIX with a Market Perform rating and target of 16. The rating matched the stock’s inability to hold above 10.4.
PLRX
HoldMar 03, 2025
Target
$2.00
Current
$1.75
Performance
26.81%
Faisal Khurshid issued a Market Perform recommendation for PLRX on Mar 03, 2025, price target set at 2. A neutral call gave way to stronger-than-expected performance, closing in on 2.
ATYR
BuyFeb 18, 2025
Target
$16.00
Current
$0.97
Performance
-74.33%
On Feb 18, 2025, ATYR was evaluated by Faisal Khurshid, who gave a Outperform rating and target of 16. Investors saw limited payoff as shares fell short of the 16 target.
KYMR
BuyDec 27, 2024
Target
$60.00
Current
$57.76
Performance
44.00%
Faisal Khurshid rated KYMR as Outperform on Dec 27, 2024, setting a price target of 60. The call has proven timely, with shares rising 44.00% toward the price target of 60.
ANIP
BuyDec 11, 2024
Target
$80.00
Current
$94.90
Performance
60.39%
On Dec 11, 2024, ANIP was given a Outperform rating by Faisal Khurshid, with a target price of 80. The stock rallied 60.39% after the rating, narrowing the gap to the target of 80 and validating the bullish stance.